bibliographic entry 6949526 [be/6949526]
https://w3id.org/oc/corpus/be/6949526

is a
content
  • Ingelheim B; Eli Lilly and Company. Safety and efficacy of empagliflozin (BI 10773) and sitagliptin versus placebo over 76 weeks in patients with type 2 diabetes. National Library of Medicine (US), 2000. https://clinicaltrials.gov/show/NCT01289990.
references